Cypress Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.81M Sell
17,210
-42
-0.2% -$3.94K 0.4% 53
2025
Q3
$1.45M Sell
17,252
-73
-0.4% -$6.01K 0.33% 61
2025
Q2
$1.37M Buy
17,325
+848
+5% +$67.4K 0.33% 58
2025
Q1
$1.48M Sell
16,477
-26,847
-62% -$2.51M 0.4% 54
2024
Q4
$4.39M Sell
43,324
-554
-1% -$57.1K 1.09% 31
2024
Q3
$4.98M Buy
43,878
+2,864
+7% +$340K 1.24% 28
2024
Q2
$5.16M Buy
41,014
+48
+0.1% +$6.18K 1.33% 25
2024
Q1
$5.47M Sell
40,966
-320
-0.8% -$39.4K 1.48% 21
2023
Q4
$4.5M Sell
41,286
-298
-0.7% -$30.9K 1.35% 25
2023
Q3
$4.26M Buy
41,584
+540
+1% +$58.2K 1.43% 20
2023
Q2
$4.79M Buy
41,044
+143
+0.3% +$16.2K 1.54% 20
2023
Q1
$4.35M Sell
40,901
-810
-2% -$87.5K 1.5% 22
2022
Q4
$4.63M Sell
41,711
-1,985
-5% -$203K 1.68% 19
2022
Q3
$3.76M Sell
43,696
-340
-0.8% -$30.4K 1.44% 23
2022
Q2
$4.01M Sell
44,036
-1,130
-3% -$100K 1.43% 22
2022
Q1
$3.71M Sell
45,166
-7,751
-15% -$611K 1.09% 30
2021
Q4
$4.06M Sell
52,917
-1,716
-3% -$137K 0.97% 35
2021
Q3
$4.1M Sell
54,633
-879
-2% -$66.9K 1.06% 29
2021
Q2
$4.32M Sell
55,512
-5,606
-9% -$417K 1.11% 27
2021
Q1
$4.5M Sell
61,118
-1,080
-2% -$79.7K 1.25% 24
2020
Q4
$4.86M Buy
62,198
+79
+0.1% +$6.04K 1.35% 21
2020
Q3
$4.92M Buy
62,119
+395
+0.6% +$30.9K 1.53% 16
2020
Q2
$4.55M Buy
61,724
+8,365
+16% +$630K 1.52% 17
2020
Q1
$3.92M Buy
53,359
+547
+1% +$43K 1.69% 16
2019
Q4
$4.58M Buy
52,812
+1,341
+3% +$110K 1.56% 19
2019
Q3
$4.13M Sell
51,471
-755
-1% -$60.5K 1.43% 21
2019
Q2
$4.18M Buy
52,226
+729
+1% +$55.8K 1.43% 20
2019
Q1
$4.09M Sell
51,497
-2,703
-5% -$202K 1.39% 22
2018
Q4
$3.95M Sell
54,200
-5,204
-9% -$367K 1.48% 20
2018
Q3
$4.02M Sell
59,404
-4,056
-6% -$258K 1.18% 27
2018
Q2
$3.68M Sell
63,460
-5,989
-9% -$338K 1.09% 30
2018
Q1
$3.61M Sell
69,449
-36,102
-34% -$1.95M 1.06% 32
2017
Q4
$5.67M Sell
105,551
-4,161
-4% -$231K 1.22% 25
2017
Q3
$6.7M Sell
109,712
-11,546
-10% -$700K 1.44% 19
2017
Q2
$7.42M Sell
121,258
-8,672
-7% -$528K 1.52% 17
2017
Q1
$7.88M Sell
129,930
-2,835
-2% -$172K 1.5% 18
2016
Q4
$7.46M Buy
132,765
+12,646
+11% +$740K 1.43% 19
2016
Q3
$7.15M Sell
120,119
-335
-0.3% -$19.6K 1.43% 21
2016
Q2
$6.62M Buy
120,454
+1,828
+2% +$97.3K 1.32% 23
2016
Q1
$5.99M Sell
118,626
-1,035
-0.9% -$50.7K 1.22% 25
2015
Q4
$6.03M Buy
119,661
+598
+0.5% +$30.1K 1.21% 25
2015
Q3
$5.61M Buy
119,063
+236
+0.2% +$12.5K 1.18% 26
2015
Q2
$6.46M Buy
118,827
+974
+0.8% +$54.6K 1.21% 25
2015
Q1
$6.46M Sell
117,853
-299
-0.3% -$16.9K 1.21% 26
2014
Q4
$6.4M Buy
118,152
+4,921
+4% +$274K 1.18% 24
2014
Q3
$6.41M Buy
113,231
+403
+0.4% +$22.6K 1.16% 24
2014
Q2
$6.23M Sell
112,828
-4,595
-4% -$251K 1.07% 31
2014
Q1
$6.36M Sell
117,423
-1,677
-1% -$86.8K 1.15% 27
2013
Q4
$5.69M Buy
119,100
+1,079
+0.9% +$49.3K 0.99% 31
2013
Q3
$5.36M Sell
118,021
-450
-0.4% -$20.5K 0.99% 31
2013
Q2
$5.25M Buy
+118,471
New +$5.29M 0.98% 31

Other funds holding MRK

Cypress Asset Management's MRK Position: Q4 2025 in Review

Cypress Asset Management reduced its Merck (MRK) stake by 0.24% in Q4 2025, selling an estimated $3.94K and leaving 17,210 shares worth $1.81M. The position accounts for 0.4% of the portfolio, ranked #53.

Cypress Asset Management first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.88M in Q1 2017. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Cypress Asset Management held 17,210 shares of Merck worth $1.81M as of Q4 2025.
  • Cypress Asset Management sold 42 Merck shares in Q4 2025, an estimated $3.94K.
  • Merck made up 0.4% of Cypress Asset Management's portfolio in Q4 2025, its #53 holding.
  • Cypress Asset Management first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Cypress Asset Management's Merck position peaked at $7.88M in Q1 2017.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.